Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2022 1
2023 3
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Type 1 diabetes management: Room for improvement.
Varkevisser RDM, Birnie E, Mul D, van Dijk PR, Aanstoot HJ, Wolffenbuttel BHR, van der Klauw MM. Varkevisser RDM, et al. J Diabetes. 2023 Mar;15(3):255-263. doi: 10.1111/1753-0407.13368. Epub 2023 Feb 17. J Diabetes. 2023. PMID: 36808864 Free PMC article.
High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies.
Al-Adwi Y, Atzeni IM, Doornbos-van der Meer B, van der Leij MJ, Varkevisser RDM, Kroesen BJ, Stel A, Timens W, Gan CT, van Goor H, Westra J, Mulder DJ. Al-Adwi Y, et al. Among authors: varkevisser rdm. EBioMedicine. 2023 Dec;98:104883. doi: 10.1016/j.ebiom.2023.104883. Epub 2023 Nov 22. EBioMedicine. 2023. PMID: 37995465 Free PMC article.
Cohort profile: the 'Biomarkers of heterogeneity in type 1 diabetes' study-a national prospective cohort study of clinical and metabolic phenotyping of individuals with long-standing type 1 diabetes in the Netherlands.
Aanstoot HJ, Varkevisser RDM, Mul D, Dekker P, Birnie E, Boesten LSM, Brugts MP, van Dijk PR, Duijvestijn PHLM, Dutta S, Fransman C, Gonera RK, Hoogenberg K, Kooy A, Latres E, Loves S, Nefs G, Sas T, Vollenbrock CE, Vosjan-Noeverman MJ, de Vries-Velraeds MMC, Veeze HJ, Wolffenbuttel BHR, van der Klauw MM; Dutch Type 1 Diabetes Biomarker group. Aanstoot HJ, et al. Among authors: varkevisser rdm. BMJ Open. 2024 Jun 19;14(6):e082453. doi: 10.1136/bmjopen-2023-082453. BMJ Open. 2024. PMID: 38904129 Free PMC article.